✦ LIBER ✦

Natural killer cell immune responses

✍ Scribed by Wayne M. Yokoyama

Book ID: 111639319
Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 452 KB
Volume: 32
Category: Article
ISSN: 0257-277X
DOI: 10.1385/ir:32:1-3:317

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adaptive immune responses mediated by na

Adaptive immune responses mediated by natural killer cells

✍ Silke Paust; Balimkiz Senman; Ulrich H. Von Andrian 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Natural killer T cell-mediated antitumor

Natural killer T cell-mediated antitumor immune responses and their clinical applications

✍ Ken-ichiro Seino; Shinichiro Motohashi; Takehiko Fujisawa; Toshinori Nakayama; M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

The immune response to primary EBV infec

The immune response to primary EBV infection: a role for natural killer cells

✍ Hilary Williams; Karen McAulay; Karen F. Macsween; Neil J. Gallacher; Craig D. H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

Regulation of immune responses by CD1d-r

Regulation of immune responses by CD1d-restricted natural killer T cells

✍ Luc Van Kaer 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 343 KB

Natural killer cells play a critical rol

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells

✍ Wargo, Jennifer A; Schumacher, Lana Y; Comin-Anduix, Begonya; Dissette, Vivian B 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 231 KB

Analysis of the natural killer mediated

Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients

✍ Asma Gati; Sylvie Da Rocha; Nadia Guerra; Bernard Escudier; Alessandro Moretta; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 394 KB 👁 1 views

## Abstract Metastatic renal cell carcinomas (MRCC) are considered as immunogeneic tumors on the basis of the clinical responses observed in patients treated by IL‐2. However, renal cell carcinoma patients are also characterized by alterations of the immune response that may compromise the immunoth